Compare Endeavour Silver Corp (EXK) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Endeavour Silver Corp vs GeneDx Holdings Corp — how do they compare? Endeavour Silver Corp trades at $8.65 (market cap $2.54B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Endeavour Silver Corp is the larger of the two by market cap, and GeneDx Holdings Corp is more actively traded (734,640 versus 7,077,330). Which is the better fit depends on your goals — on Pluang, investors hold Endeavour Silver Corp for 25 Days and GeneDx Holdings Corp for 19 Days on average.
| EXK | WGS | |
|---|---|---|
Market Cap | $2.54B | $2.02B |
Volume | 7,077,330 | 734,640 |
Sector | Basic Materials | Health |
52-Week High | $14.12 | $167.51 |
52-Week Low | $7.07 | $34.51 |
Typical Hold Time | 25 Days | 19 Days |
Enterprise Value | $2.54B | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Endeavour Silver (EXK) trades at $8.65, up 3.97% today. The technical outlook is bearish, with moving averages signaling a downtrend, while fundamentals show a transition from a net loss in 2025 to a projected profit in 2026. Recent news highlights operational progress at the Terronera and Kolpa mines, though temporary disruptions occurred. Analyst sentiment is strongly positive, with 78.57% recommending Buy.
The stock presents a growth opportunity driven by mine expansions and favorable silver prices, but faces risks from operational hiccups and high valuation multiples. Investors should weigh the bullish analyst consensus against execution risks and market volatility for silver equities.
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Endeavour Silver Corp
Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.
Read more on EXK →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
